Does HPV-16 seropositivity correlate with T-cell distribution providing additional prognostic information in infected HNSCC patients?
It is widely accepted that infection with Human Papilloma Virus (HPV) confers better outcomes and survival rates in head and neck squamous cell carcinoma (HNSCC) patients (80% 5-year survival) compared with HPV-negative counterparts (50% 5-year survival),regardless of treatment modality. It is hypot...
Main Author: | |
---|---|
Published: |
University of Hull
2016
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.705737 |